Effect of Pregnancy on Intracellular Tenofovir Diphosphate Exposure and Thresholds following Oral Emtricitabine-Tenofovir Disoproxil fumarate Pre-Exposure Prophylaxis: A Directly Observed Dosing Study

Clicks: 17
ID: 328537
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #396 of 502 articles by views in The Journal of infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 502 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
INTRODUCTION: Intraerythrocytic tenofovir diphosphate (TFV-DP) concentrations from emtricitabine/tenofovir disoproxil fumarate (F/TDF) pre-exposure prophylaxis (PrEP) measured in dried blood spots (DBS) are ∼30-40% lower during pregnancy, but data on TFV-DP concentrations in peripheral blood mononuclear cells (PBMCs) are limited. We evaluated the effect of pregnancy on intracellular TFV-DP concentrations in PBMCs. METHODS: Directly observed dosing (DOD) of daily oral F/TDF was administered to 18 healthy non-pregnant and 18 pregnant Kenyan women without HIV for eight weeks. Blood for DBS and PBMC was collected weekly for non-pregnant and bi-weekly for pregnant women. TFV-DP concentrations in DBS and PBMCs were quantified using validated liquid chromatography-tandem mass spectrometry. Steady-state fitted TFV-DP concentrations in PBMC and DBS were compared between pregnant and non-pregnant women. RESULTS: Median (IQR) age was 23 (20-27) years and gestational age was 16 (14-20) weeks for pregnant women at enrollment. Median (IQR) Cockroft Gault-estimated creatinine clearance was 131 (113-146) mL/Min for non-pregnant versus 176 (154-196) mL/Min for pregnant women. 1922 of 1925 (99.8%) expected doses were directly observed. Fitted steady-state median (IQR) TFV-DP concentrations in DBS were 1545 (1203, 1887) fmol/punch in non-pregnant versus 919 (835, 1003) fmol/punch in pregnant women [percent change: 40.5%, 95%CI (29.5%, 51.5%); p<0.001]. Modeled steady-state geometric mean (95%CI) PBMC TFV-DP concentrations were 56.2 (48.0, 65.8) fmol/106 cells in non-pregnant versus 47.8 (40.4, 56.5) fmol/106 cells in pregnant women [geometric mean ratio (GMR, 95%CI): 0.85 (0.68, 1.06); p=0.15]. CONCLUSION: Steady-state TFV-DP concentrations in PBMCs were reassuringly not meaningfully different between pregnant and non-pregnant women.
Reference Key
openalex_W7212296659 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Linxuan Wu, Peter L. Anderson, Samantha MaWhinney, M. Saina, Nelly Mugo, Clare Brown, Nina Akelo, Katherine Thomas, Jennifer F Morton, Elex Hill, Kenneth Ngure, Elena A. Rechkina, Lane Bushman, Deborah Donnell, Kenneth K. Mugwanya
Are you one of these authors? Claim your profile
Journal The Journal of infectious diseases
Year 2026
DOI
10.1093/infdis/jiag460
URL
https://doi.org/10.1093/infdis/jiag460
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.